{
    "2021-08-24": [
        [
            {
                "time": "",
                "original_text": "持续发力全球市场 甘李药业赖脯胰岛素在黎巴嫩获批",
                "features": {
                    "keywords": [
                        "甘李药业",
                        "赖脯胰岛素",
                        "黎巴嫩",
                        "获批"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "甘李药业：赖脯胰岛素注射液获得黎巴嫩注册批件",
                "features": {
                    "keywords": [
                        "甘李药业",
                        "赖脯胰岛素注射液",
                        "黎巴嫩",
                        "注册批件"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "高瓴资本概念股整体活跃，泰格、金域、凯莱英、恩捷、甘李药业均大涨",
                "features": {
                    "keywords": [
                        "高瓴资本",
                        "甘李药业",
                        "泰格",
                        "金域",
                        "凯莱英",
                        "恩捷",
                        "大涨"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}